Anti-inflammatory effect of pregabalin on acetic acid-induced colitis in the rats

Azadeh Motavallian , Ehsan Zamani , Saba Bouzari, Farzam Rezaeyan, Paridokht Karimian, Mehdi Evazalipour


Background and purpose: Inflammatory bowel disease (IBD) is a chronic gastrointestinal disease characterized by the inflammation of the intestine. The available medicinal treatments for IBD are not efficacious enough since they exert various adverse effects. Therefore, the search for new therapeutic agents should be continued. The present study aimed to assess the anti-inflammatory effects of pregabalin on acetic acid-induced colitis in rats.

Experimental approach: Using 2 mL of 3% acetic acid solution, colitis was intra-rectally induced in rats. Animals were randomly divided into 6 groups including the normal group, colitis control group, pregabalin treatment groups (30, 50, and 100 mg/kg; i.p., respectively), and dexamethasone treatment group                                     (1 mg/kg; i.p.). Macroscopic, microscopic, and biochemical (myeloperoxidase, tumor necrosis factor-alpha, interleukin-6, and interleukin-1 beta) examinations were used to evaluate the efficacy of pregabalin in the inflamed colon.

Findings/Results: All the applied doses of pregabalin significantly decreased the severity of macroscopic and microscopic colonic damages including ulcer severity, ulcer area, percentage of necrosis, and total colitis index compared to the colitis control group. These results were confirmed by the reduced colonic concentration of tumor necrosis factor-alpha, interleukin-6, interleukin-1 beta, and myeloperoxidase activity.

Conclusion and implications: Results of this study indicated that pregabalin administration has beneficial effects upon the treatment of experimental colitis, which might be partly due to its anti-inflammatory properties.


Keywords: Experimental colitis; Pregabalin; Pro-inflammatory cytokines; Rat.

Full Text:



Axelrad JE, Lichtiger S, Yajnik V. Inflammatory bowel disease and cancer: the role of inflammation, immunosuppression, and cancer treatment. World J Gastroenterol. 2016;22(20):4794-4801.

DOI: 10.3748/wjg.v22.i20.4794.

Strober W, Fuss IJ. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology. 2011;140(6):1756-1767.

DOI: 10.1053/j.gastro.2011.02.016.

Braus NA, Elliott DE. Advances in the pathogenesis and treatment of IBD. Clin Immunol. 2009;132(1):1-9.

DOI: 10.1016/j.clim.2009.02.006.

Ma X, Sun Q, Sun X, Chen D, Wei C, Yu X, et al. Activation of GABA(A) receptors in colon epithelium exacerbates acute colitis. Front Immunol. 2018;9:987-1004.

DOI: 10.3389/fimmu.2018.00987.

Zizzo MG, Serio R. Therapeutic potential of the gabaergic system in ulcerative colitis: current status and perspectives. Dig Dis Sci. 2017;62(10):2780.

DOI: 10.1007/s10620-017-4709-5.

Aggarwal S, Ahuja V, Paul J. Attenuated GABAergic signaling in intestinal epithelium contributes to pathogenesis of ulcerative colitis. Dig Dis Sci. 2017;62(10):2768-2779.

DOI: 10.1007/s10620-017-4662-3.

Sanei MH, Hadizadeh F, Adibi P, Alavi SA. Inflammatory cells' role in acetic acid-induced colitis. Adv Biomed Res. 2014;3:193.

DOI: 10.4103/2277-9175.140666.

Manjushree N, Chakraborty A, Shashidhar K, Narayanaswamy S. A review of the drug pregabalin. Int J Basic Clin Pharmacol. 2015;4(4):601-605.

DOI: 10.18203/2319-2003.ijbcp20150359.

Sills GJ. The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol. 2006;6(1):108-113.

DOI: 10.1016/j.coph.2005.11.003.

Marks DM, Patkar AA, Masand PS, Pae CU. Does pregabalin have neuropsychotropic effects?: A short perspective. Psychiatry Investig. 2009;6(2):55-58.

DOI: 10.4306/pi.2009.6.2.55.

Kumar N, Laferriere A, Yu JS, Leavitt A, Coderre TJ. Evidence that pregabalin reduces neuropathic pain by inhibiting the spinal release of glutamate. J Neurochem. 2010;113(2):552-561.

DOI: 10.1111/j.1471-4159.2010.06625.x.

Abu-rish EY, Mansour AT, Mansour HT, Dahabiyeh LA, Aleidi SM, Bustanji Y. Pregabalin inhibits in vivo and in vitro cytokine secretion and attenuates spleen inflammation in lipopolysaccharide/ Concanavalin A-induced murine models of inflammation. Sci Rep. 2020;10(1):4007-4017.

DOI: 10.1038/s41598-020-61006-1.

Nunes EA, Canever L, Oliveira LD, Luca R, Quevedo J, Zugno A, et al. Effects of pregabalin on behavioral alterations induced by ketamine in rats. Braz J Psychiatry. 2012;34(3):329-333.

DOI: 10.1016/j.rbp.2012.02.005.

Salimzade A, Hosseini-Sharifabad A, Rabbani M. Comparative effects of chronic administrations of gabapentin, pregabalin and baclofen on rat memory using object recognition test. Res Pharm Sci. 2017;12(3):204-210.

DOI: 10.4103/1735-5362.207201.

Motavallian A, Minaiyan M, Rabbani M, Mahzouni P, Andalib S. Anti-inflammatory effects of alosetron mediated through 5-HT(3) receptors on experimental colitis. Res Pharm Sci. 2019;14(3):228-236.

DOI: 10.4103/1735-5362.258489.

Mahdavi NS, Talebi A, Minaiyan M. Ameliorative effect of galantamine on acetic acid-induced colitis in rats. Res Pharm Sci. 2019;14(5):391-399.

DOI: 10.4103/1735-5362.268199.

Motavallian-Naeini A, Minaiyan M, Rabbani M, Mahzuni P. Anti-inflammatory effect of ondansetron through 5-HT3 receptors on TNBS-induced colitis in rat. EXCLI J. 2012;11:30-44.

PMID: 27350767.

Cooper H, Murthy S, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993;69(2):238-249.

PMID: 8350599.

Dieleman LA, Palmen MJ, Akol H, Bloemena E, Pena AS, Meuwissen SG. Chronic experimental colitis induced by dextran sulfate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol. 1998;114(3):385-391.

DOI: 10.1046/j.1365-2249.1998.00728.x.

Nacife VP, Soeiro MN, Gomes RN, D'Avila H, Castro-Faria Neto HC, Meirelles MN. Morphological and biochemical characterization of macrophages activated by carrageenan and lipopolysaccharide in vivo. Cell Struct Funct. 2004;29(2):27-34.

DOI: 10.1247/csf.29.27.

Aşcı S, Demirci S, Aşcı H, Doğuç DK, Onaran İ. Neuroprotective effects of pregabalin on cerebral ischemia and reperfusion. Balkan Med J. 2016;33(2):221-227.

DOI: 10.5152/balkanmedj.2015.15742.

Kilic FS, Kaygisiz B, Aydin S, Yildirim C, Karimkhani H, Oner S. Pregabalin attenuates carrageenan-induced acute inflammation in rats by inhibiting proinflammatory cytokine levels. Eurasian J Med. 2018;50(3):156-159.

DOI: 10.5152/eurasianjmed.2018.17261.

Yamaguchi K, Kumakura S, Someya A, Iseki M, Inada E, Nagaoka I. Anti-inflammatory actions of gabapentin and pregabalin on the substance P-induced mitogen-activated protein kinase activation in U373 MG human glioblastoma astrocytoma cells. Mol Med Rep. 2017;16(5):6109-6115.

DOI: 10.3892/mmr.2017.7368.

Diop L, Raymond F, Fargeau H, Petoux F, Chovet M, Doherty AM. Pregabalin (CI-1008) inhibits the trinitrobenzene sulfonic acid-induced chronic colonic allodynia in the rat. J Pharmacol Exp Ther. 2002;302(3):1013-1022.

DOI: 10.1124/jpet.302.3.1013.

Zhou Q, Nicholas Verne G. NMDA Receptors and colitis: basic science and clinical implications. Rev Analg. 2008;10(1):33-43.

Analg. 2008;10(1):33-43.

DOI: 10.3727/154296108783994013.

Zhou Q, Caudle RM, Price DD, Del Valle-Pinero AY, Verne GN. Selective up-regulation of NMDA-NR1 receptor expression in myenteric plexus after TNBS induced colitis in rats. Mol Pain. 2006; 2(1):3-12.

DOI: 10.1186/1744-8069-2-3.

Ma T, Cheng Q, Chen C, Luo Z, Feng D. Excessive activation of NMDA receptors in the pathogenesis of multiple peripheral organs via mitochondrial dysfunction, oxidative stress, and inflammation. SN Compr Clin Med. 2020;2(5):551-569.

DOI: 10.1007/s42399-020-00298-w.

Érces D, Varga G, Fazekas B, Kovács T, Tőkés T, Tiszlavicz L, et al. N-methyl-D-aspartate receptor antagonist therapy suppresses colon motility and inflammatory activation six days after the onset of experimental colitis in rats. Eur J Pharmacol. 2012;691(1-3):225-234.

DOI: 10.1016/j.ejphar.2012.06.044.

Kato E, Matsuzawa R, Kobayashi S, Fukushima T, Maekawa M, Hori Y. Effects of pregabalin on spinal d-serine content and NMDA receptor-mediated synaptic transmission in mice with neuropathic pain. Neurosci Lett. 2017;636:270-275.

DOI: 10.1016/j.neulet.2016.10.053.

Hamilton MJ, Frei SM, Stevens RL. The multifaceted mast cell in inflammatory bowel disease. Inflamm Bowel Dis. 2014;20(12):2364-2378.

DOI: 10.1097/MIB.0000000000000142.

Reddy ST, Wadleigh DJ, Herschman HR. Transcriptional regulation of the cyclooxygenase-2 gene in activated mast cells. J Biol Chem. 2000;275(5):3107-3113.

DOI: 10.1074/jbc.275.5.3107.

Park S, Ahn ES, Han DW, Lee JH, Min KT, Kim H, Hong YW. Pregabalin and gabapentin inhibit substance P-induced NF-κB activation in neuroblastoma and glioma cells. J Cell Biochem. 2008;105(2):414-423.

DOI: 10.1002/jcb.21837.

Saito YA, Almazar AE, Tilkes KE, Choung RS, Van Norstrand MD, Schleck CD, et al. Randomised clinical trial: pregabalin vs placebo for irritable bowel syndrome. Aliment Pharmacol Ther. 2019;49(4): 389-397.

DOI: 10.1111/apt.15077.


  • There are currently no refbacks.

Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.